News | April 17, 2026
Moberg Pharma reports 2025 annual results, maintains strong cash position
The company reported net revenue of SEK 13.5 million for the full year 2025
The company reported net revenue of SEK 13.5 million for the full year 2025
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Former Wavemaker executive to lead media strategy and digital transformation agenda
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility
Research by NITI Aayog and All India Institute of Medical Sciences has shown that at least 30% of trauma deaths are linked to delays in emergency response
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
Subscribe To Our Newsletter & Stay Updated
